Silk Road Medical, Inc (SILK)
27.49
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024
Silk Road Medical Revenue
Silk Road Medical had revenue of $51.24M in the quarter ending June 30, 2024, with 13.12% growth. This brings the company's revenue in the last twelve months to $191.43M, up 17.53% year-over-year. In the year 2023, Silk Road Medical had annual revenue of $177.13M with 27.77% growth.
Revenue (ttm)
$191.43M
Revenue Growth
+17.53%
P/S Ratio
5.63
Revenue / Employee
$403,863
Employees
474
Market Cap
1.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 177.13M | 38.50M | 27.77% |
Dec 31, 2022 | 138.64M | 37.16M | 36.62% |
Dec 31, 2021 | 101.48M | 26.25M | 34.89% |
Dec 31, 2020 | 75.23M | 11.87M | 18.74% |
Dec 31, 2019 | 63.35M | 28.80M | 83.33% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSILK News
- 1 year ago - Boston Scientific Announces Results for Third Quarter 2024 - PRNewsWire
- 1 year ago - Boston Scientific Closes Acquisition of Silk Road Medical, Inc. - PRNewsWire
- 1 year ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY and SILK on Behalf of Shareholders - Accesswire
- 1 year ago - SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK - Business Wire
- 1 year ago - Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures - GlobeNewsWire
- 1 year ago - Boston Scientific Announces Results for Second Quarter 2024 - PRNewsWire
- 1 year ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. - PRNewsWire
- 1 year ago - Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal - Benzinga